Beranda › Tumor Otak › New York › New York City
Uji klinis Tumor Otak di New York City, NY
25 studi untuk Tumor Otak mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Menerima pesertaFase 2
- New York University Langone's Perlmutter Cancer Institute, New York
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Menerima pesertaFase 2
- Columbia University Irving Medical Center, New York
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Menerima pesertaFase 1/2
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Menerima pesertaFase 2
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Menerima pesertaFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Menerima pesertaFase 2
- Memorial Sloan-Kettering Cancer Center, New York
Chronic CED of TPT for Recurrent Malignant Glioma
Menerima pesertaFase 1
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
European Prospective Investigation Into Childhood Cancer
Menerima pesertaStudi observasional
- Columbia University Irving Medical Center, New York
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
Menerima pesertaFase 1/2
- Lenox Hill Brain Tumor Center, New York
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Menerima pesertaFase 3
- Lenox Hill Brain Tumor Center, New York
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Menerima peserta
- Lenox Hill Brain Tumor Center, New York
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Menerima peserta
- Lenox Hill Brain Tumor Center, New York
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
Menerima pesertaFase 1/2
- Lenox Hill Brain Tumor Center, New York
A Study of Sotorasib in People With Brain Tumors
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Menerima pesertaFase 1
- Columbia University Irving Medical Center, New York
rTMS for Postoperative Brain Tumor Patients
Menerima peserta
- Columbia University Irving Medical Center, New York
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Menerima pesertaFase 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Menerima pesertaFase 2
- Lenox Hill Brain Tumor Center, New York
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
Menerima pesertaFase 1/2
- Weill Cornell Medicine, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
FUS Etoposide for DMG
Menerima pesertaFase 1
- Columbia University Irving Medical Center, New York
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
Menerima pesertaFase 4
- New York-Presbyterian/Weill Cornell Medical Center, New York
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
Menerima peserta
- Memorial Sloan Kettering Cancer Center, New York
Uji klinis Tumor Otak di kota lain
- Houston, TX35 studi
- Boston, MA28 studi
- Washington, DC20 studi
- Los Angeles, CA16 studi
- Miami, FL15 studi
- Durham, NC14 studi
- St. Louis, MO12 studi
- Rochester, MN11 studi
- Chicago, IL11 studi
- Cleveland, OH11 studi
- Baltimore, MD11 studi
- Seattle, WA11 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.